Search

everythinglearnresearchcommunity

for

Search:↓

Common baldness treatments include cosmetic methods, medication like minoxidil, and surgery, but no cure exists.

The document concludes that androgenetic alopecia is common, has a genetic link, and can be diagnosed and treated with medications like finasteride and minoxidil.

Finasteride increases hair count and improves hair growth with low risk of side effects.

Permanent hair removal with lasers is the most promising treatment for excessive hair growth.

Both hormonal and non-hormonal therapies improve hair growth in women, but non-hormonal methods may be more effective with fewer side effects.

Hair restoration can be achieved through non-surgical treatments like minoxidil, antiandrogens, phototherapy, and PRP procedures, or through surgical methods like hair transplantation. Continued treatment is needed to maintain results, and full results are visible after 12-18 months.

Menopausal acne is mainly caused by hormonal changes and can be managed with topical treatments, lifestyle changes, and sometimes medication.

AT-Grow, a natural product, might help with a common type of hair loss by reducing DHT levels.

Mycophenolic acid may help hair growth, a combination treatment improves hair thickness in male hair loss, and early treatment of frontal fibrosing alopecia is important.

The document concludes that hair loss in women can be treated with topical treatments or hormone therapy depending on the cause.

Topical minoxidil is the primary treatment for female pattern hair loss in India.

Female pattern hair loss, common in women, can be treated with oral antiandrogens and topical minoxidil, but these are more effective at preventing further loss than regrowing hair. Other helpful methods include counseling, cosmetic camouflage, and hair transplantation. Treatment must continue for effects to last and it may take up to 2 years to see results.

Female pattern hair loss causes thinning hair on top of the scalp, treatable with limited success.

Topical minoxidil helps hair regrowth in over 50% of men and women.

Integrative hair therapy improved hair loss and regrowth.

Completing a 14-day proxalutamide treatment significantly lowers death rates in hospitalized COVID-19 patients.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Flutamide helps with prostate cancer and some skin conditions but can harm the liver.

Vitex negundo has potential health benefits, including anti-inflammatory and anti-cancer effects.

PrEP doesn't increase STI risk in high-risk men, anti-androgen drugs may lower ICU admission for male COVID-19 patients, a 3-point injection is better for crow's feet, and the 'Geriatric-8' tool could help assess frailty in older skin cancer patients.

The method reliably profiles eicosanoids and shows epitestosterone reduces their levels, similar to common anti-inflammatory drugs.

Thai rice bran extracts, especially from Tubtim Chumphae rice, can significantly reduce the activity of hair loss genes, with x-tocopherol showing potential as an anti-hair loss product.

Topical minoxidil effectively treats Female Pattern Hair Loss in women of all ages and hormone levels, but evidence for antiandrogens is limited.

Levamisole and finasteride can reduce DHT production, potentially preventing phenytoin-induced gum overgrowth.

Spironolactone may help reduce hair growth and testosterone levels in some women with hirsutism.

Certain hormones can reduce skin oil and hair growth, potentially helping treat acne and excessive hair in women.

RU58841, a substance from France, can potentially block the effects of hormones that cause hair loss and excessive hair growth, performing better than a similar substance, cyproterone acetate.

Minoxidil is an effective and safe treatment for common hair loss when applied to the skin, but more research is needed for optimal use.

Treatments for PCOS aim to reduce androgen levels and improve insulin sensitivity to lower cardiometabolic risk.

The nature of the side chain in RU 58841 derivatives greatly affects its AR affinity, with the N-(iodopropenyl) derivative 13 showing the highest AR binding affinity, suggesting its potential for developing high-affinity radioiodinated AR radioligands.